主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MLTX
#2020
MoonLake Immunotherapeutics Class A Ordinary Shares
17.510
0
-0.68%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.68%
每月变动
+7.49%
6个月变化
+83.16%
年变化
+83.16%
前一天收盘价
17.630
0
Open
17.510
0
Bid
Ask
Low
17.510
0
High
17.510
0
交易量
76
市场
股票
医疗保健
MLTX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
11.93 M
11.93 M
39.15 M
62.87 M
63.28 M
71.73 M
—
Valuation ratios
Enterprise value
—
—
1.72 B
10.98 B
10.22 B
2.5 B
19.59 B
Price to earnings ratio
—
—
-6.49
-81.58
-28.65
-3.73
-39.86
Price to sales ratio
—
—
995.06
19.31 K
-80.7 K
1 418.42
3 765.23
Price to cash flow ratio
—
—
-5.79
-68.38
-29.2
4.33
-27.34
Price to book ratio
—
—
6.62
5.9
7.62
2.79
6.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
-0.04
-0.65
-0.07
-0.25
0.54
0.51
Return on equity %
—
0.64
-0.73
-0.07
-0.26
0.75
0.7
Return on invested capital %
—
—
-427.73
-1 699.61
-2 635.87
2 828.78
2 975.79
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
-20 K
-35.73 K
339.19 K
40.87 K
97.97 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
-15.36 K
-23.77 K
281.93 K
37.95 K
77.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.93
0.21
9.98
51.59
21.11
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0
0
-0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
0.17
0.65
Long term debt to total equity ratio
0.01
0
—
—
—
0.24
0.89
Per share metrics
Operating cash flow per share
—
-0
-1.9
-0.87
-1.85
3.04
3.08
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
0
2.46
10.4
7.13
6.11
26.43
Net current asset value per share
—
0
2.61
10.47
7.54
6.54
28.23
Tangible book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
Working capital per share
—
-0.01
2.34
10.26
7.19
5.84
25.95
Book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
新闻
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
MoonLake股价因axSpA试验数据积极而飙升
MoonLake stock surges on positive axSpA trial data
InvestingPro公允价值预测后MoonLake股价飙升63%
MoonLake stock surges 63% after InvestingPro Fair Value call
MoonLake公布轴性脊柱关节炎2期临床试验阳性数据
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
BTIG重申Moonlake Immunotherapeutics股票买入评级,静待数据公布
BTIG reiterates Buy rating on Moonlake Immunotherapeutics stock ahead of data